Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6660)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2013 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li CZ, Cheng LF, Li QS, Wang ZQ, Yan JH. Antiviral therapy delays esophageal variceal bleeding in hepatitis B virus-related cirrhosis. World J Gastroenterol 2013; 19(40): 6849-6856 [PMID: 24187460 DOI: 10.3748/wjg.v19.i40.6849] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v19/i40/6849.htm |
| Number | Citing Articles |
| 1 |
Xiaoyong Xu, Chaoxue Zhang, Chen Shi, Naizhong Hu, Bin Sun, Derun Kong, Jianming Xu. Antiviral therapy effectively improves liver hemodynamics as evidenced by serum biomarker and contrast-enhanced ultrasound examinations in patients with hepatitis B cirrhosis. PeerJ 2018; 6: e5484 doi: 10.7717/peerj.5484
|
| 2 |
Mauro Viganò, Alessandro Loglio, Pietro Lampertico. Long-term Outcomes in Patients with HBV Treated with Antiviral Agents. Current Hepatology Reports 2018; 17(4): 502 doi: 10.1007/s11901-018-0440-8
|
| 3 |
Jui-Ting Hu, Sien-Sing Yang. Variceal Bleeding in Liver Cirrhosis. 2021; : 41 doi: 10.1007/978-981-15-7249-4_4
|
| 4 |
甜静 张. Advances in Antiviral Therapy for Hepatitis B Cirrhosis in the Compensated Stage. Advances in Clinical Medicine 2024; 14(04): 41 doi: 10.12677/acm.2024.144985
|
| 5 |
Irene Rapti, Stephanos Hadziyannis. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues. World Journal of Hepatology 2015; 7(8): 1064-1073 doi: 10.4254/wjh.v7.i8.1064
|
| 6 |
Juan G. Abraldes, Puneeta Tandon. PanVascular Medicine. 2015; : 3667 doi: 10.1007/978-3-642-37078-6_199
|
| 7 |
Hong Zhou, Han Hu, Maoyong Tian, Jun Chu, Caiyun Tian, Yanqing Yang, Shide Lin, Chiara Ricci. Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/4217512
|
| 8 |
Manuela Merli, Roberto J. Groszmann. Portal Hypertension VI. 2016; : 215 doi: 10.1007/978-3-319-23018-4_23
|
| 9 |
Lingling He, Xiaohui Ye, Jiali Ma, Ping Li, Yu Jiang, Julong Hu, Junru Yang, Yuling Zhou, Xiuxia Liang, Yijun Lin, Hongshan Wei. Antiviral therapy reduces rebleeding rate in patients with hepatitis B-related cirrhosis with acute variceal bleeding after endotherapy. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1020-2
|
| 10 |
Lan‐Qing Li, En‐Qiang Chen. Editorial: in the era of effective antiviral therapy, long‐term dynamic endoscopic monitoring does not seem to be necessary for all CHB patients with compensated cirrhosis. Alimentary Pharmacology & Therapeutics 2023; 57(12): 1467 doi: 10.1111/apt.17487
|
| 11 |
Maxime Mallet, Marika Rudler, Dominique Thabut. Variceal bleeding in cirrhotic patients. Gastroenterology Report 2017; 5(3): 185 doi: 10.1093/gastro/gox024
|
| 12 |
Yuanyuan Kong, Tingting Lv, Min Li, Lianghui Zhao, Tongtong Meng, Shanshan Wu, Wei Wei, Qian Zhang, Sha Chen, Hong You, Sabela Lens, Hitoshi Yoshiji, Sven Francque, Emmanouil Tsochatzis, Shiv K. Sarin, Mattias Mandorfer, Jidong Jia. Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease. Hepatology International 2022; 16(5): 1052 doi: 10.1007/s12072-022-10369-w
|
| 13 |
Glenda Grossi, Mauro Viganò, Alessandro Loglio, Pietro Lampertico. Hepatitis B virus long‐term impact of antiviral therapy nucleot(s)ide analogues (NUCs). Liver International 2017; 37(S1): 45 doi: 10.1111/liv.13291
|
| 14 |
Juan G. Abraldes, Puneeta Tandon. Therapies: Drugs, Scopes and Transjugular Intrahepatic Portosystemic Shunt - When and How?. Digestive Diseases 2015; 33(4): 524 doi: 10.1159/000374101
|
| 15 |
Xiaotao Jiang, Linling Xie, Cihui Huang, Yishen Liu, Haining Liu, Binqian Liu, Liang Zheng. Oral oxymatrine for hepatitis B cirrhosis. Medicine 2018; 97(49): e13482 doi: 10.1097/MD.0000000000013482
|
| 16 |
Juan G. Abraldes, Puneeta Tandon. PanVascular Medicine. 2014; : 1 doi: 10.1007/978-3-642-37393-0_199-1
|
| 17 |
Qun Zhang, Shuaishuai Niu, Li Yang, Bingbing Zhu, Ke Shi, Xiaohua Zhang, Yi Zhang, Yufei Bi, Yongping Mu, Xianbo Wang. A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1062172
|
| 18 |
Seyed Mohsen Dehghani, Zeinab Rashidinia, Iraj Shahramian, Ali Bazi, Amir Saeed, Eslam Shorafa. Risk Factors of Esophageal Bleeding in Children with Various Etiologies of Liver Cirrhosis – A Single-Center Report from Iran. Serbian Journal of Experimental and Clinical Research 2022; 23(2): 135 doi: 10.2478/sjecr-2019-0049
|
| 19 |
|